Results: Univariate analysis on the results of treatments on 80 Non-Hodgkin's Lymphoma patients with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone therapy and DHAP (Dexamethasone, Cisplatin, Cytosar) therapy reveal that the factors that affect the Complete Remission, Overall survival, Disease-Free survival are: + B symptoms: Patients without B symptoms have better outcome than those with B symptoms.